Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% (RLD Atrovent) had estimated annual sales of USD 22 million in the U.S. (IQVIA MAT December 2024). Read also: Lupin's Generic Entresto Approved ...
company having received an approval from the U.S. FDA for its Abbreviated New Drug Application for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% (21 mcg/spray), to market a generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback